Oxford University signs universal flu vaccine development deal with US startup BWV
Development of a vaccine candidate with potential to save millions worldwide will be accelerated in commercialisation deal with Blue Water Vaccines.
Oxford University Innovation Q4 and Y2018 Update
Oxford University Innovation breaks its own spinout generation record as the spinout community attracts more investment than ever before.
Oxford University Innovation Incubator relaunches with new startup offer
OUI Incubator unveils with new deal on equity and access to finance through the OUI Future Fusion programme.
Oxford company PalaeoPi launches to offer automated 3D digitisation of objects
The Oxford University spinout will be offering automated photogrammetry to the archaeology and heritage markets.
OMass raises £14m to boost drug development programme
The Oxford University spinout plans to use the investment to fuel its structural mass spectrometry to identify new medicines.
Oxford firm launches to develop quantum-era sensor technology
Oxford HighQ, a spinout from Oxford University, aims to revolutionise chemical and nanoparticle sensor technology with ‘quantum’ sensors up to 10,000 times more sensitive than current counterparts.
Oxford University Innovation Q3 2018 Update
Oxford spinouts secure £130m in August alone as OUI heads towards a potentially record breaking year for spinout generation.
Oxford firm launches to predict and prevent heart attacks years before they happen
Oxford University spinout Caristo Diagnostics utilises standard CT scans to identify potentially heart-stopping plaques.
Regenerative medicine spinout OxStem launches subsidiaries to tackle diabetes and inflammation
Subsidiaries of the Oxford University spinout, OxStem Immuno and OxStem Beta, will draw on research from the institution.
Oxford University Innovation launches social enterprise support
Oxford University Innovation unveils support for impact-driven businesses from academic ideas.
